2025 International Congress Archives - Page 101 of 181

Local field potential vs image guided programming: clinical trial for optimization the deep brain stimulation in Parkinson’s disease

A. Martínez Reyes, J. Bejarano Hernández, A. Cadena Fernández, C. Lázaro Hernández, F. Valldeoriola Serra, A. Sánchez Gómez (Barcelona, Spain)
Loneliness accelerates parkinsonism decline in parkinsonian community-dwelling older adults

D. Gonzalez, M. Wilson, M. Tosin, M. Roy, C. Goetz (Chicago, USA)
Long term real-world monitoring supports the superiority of adaptive deep brain stimulation: preliminary data on three patients with Parkinson’s disease

L. Caffi, R. Habib, L. Borellini, E. Mailland, F. Cogiamanian, M. Arlotti, L. Rossi, S. Bonvegna, C. Palmisano, S. Marceglia, A. Priori, G. Pezzoli, M. Locatelli, IU. Isaias (Würzburg, Germany)
Long-term analysis of subthalamic local field potentials (LFP) in Parkinson’s disease: Insights into circadian rhythms, medication, and personalized treatment effects

V. Livneh, R. Naivelt, M. Zutta, Z. Katzir, R. Monteoriano, I. Strauss, K. Avirame, A. Socher, G. Morris, I. Maidan (Tel Aviv, Israel)
Long-Term Benefits of Weekly Group Physiotherapy in Slowing Parkinson’s Progression:A 12-Month Non-Randomized Controlled Trial

E. Tardelli, M. Piemonte, B. Rosa, P. Igarashi, C. Dias (São Paulo, Brazil)
Long-Term Dementia Risk in the General Parkinson Disease Population

J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)
Long-Term Effect of Dopaminergic Treatment on gait in De Novo Parkinson’s Disease: the DNA mobile health technology longitudinal study

A. Pilotto, C. Zatti, A. Rizzardi, C. Hansen, J. Gerritz, R. Romijnders, M. Catania, A. Lupini, W. Maetzler, A. Padovani (Brescia, Italy)
Long-Term Effect of Opicapone in Parkinson’s Patients Without Motor Complications: 1.5-year EPSILON Study Findings

J. Ferreira, O. Rascol, F. Stocchi, A. Antonini, H. Brigas, J. Moreira, JF. Rocha, M. Fonseca, J. Holenz, W. Poewe (Lisbon, Portugal)
Long-Term Effectiveness and Tolerability of Vatiquinone in an Adult Friedreich’s Ataxia Population

C. Werner, S. Perlman, J. Blaize, M. Rance, J. Cherry, O. Zhang, L. Golden, D. Lynch, T. Zesiewicz (Frankfurt, Germany)
Long-term effects of a periodic intensive rehabilitation program in People with Parkinson’s Disease

Y. Yamaguchi, J. Ogawa, K. Kakegawa, M. Matsuda (Ginza, Chuo-ku, Japan)